应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ZY Zymergen, Inc.
停牌 03-25 15:42:33 EDT
2.43
+0.00
0.00%
最高
2.43
最低
2.43
成交量
0.00
今开
2.43
昨收
2.43
日振幅
0.00%
总市值
2.54亿
流通市值
1.35亿
总股本
1.04亿
成交额
572.63万
换手率
0.00%
流通股本
5,538万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
亚宝药业(600351.SH):ZY-A001获得药物临床试验批准通知书
智通财经 · 02-14
亚宝药业(600351.SH):ZY-A001获得药物临床试验批准通知书
合成生物巨头,为什么一个个倒下了?
美股研究社 · 2024-08-28
合成生物巨头,为什么一个个倒下了?
加载更多
公司概况
公司名称:
Zymergen, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Zymergen Inc.于2013年在特拉华州注册成立。他们与Nature合作,设计,开发和商业化基于生物的突破性产品,这些产品将为广泛行业的客户提供非凡的价值。他们的首批创新产品包括专为电子公司设计的,可用于新型智能设备(包括可卷起的平板电脑)和天然紫外线防护产品的薄膜。
发行价格:
--
{"stockData":{"symbol":"ZY","market":"US","secType":"STK","nameCN":"Zymergen, Inc.","latestPrice":2.43,"timestamp":1666123200000,"preClose":2.43,"halted":3,"volume":0,"delay":0,"floatShares":55375154,"shares":104355336,"eps":-3.5414,"marketStatus":"停牌","change":0,"latestTime":"03-25 15:42:33 EDT","open":2.43,"high":2.43,"low":2.43,"amount":5726327.805341,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.5414,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1742932800000},"marketStatusCode":2,"adr":0,"listingDate":1619064000000,"exchange":"NASDAQ","adjPreClose":2.43,"volumeRatio":0},"requestUrl":"/m/hq/s/ZY/","defaultTab":"news","newsList":[{"id":"2511658132","title":"亚宝药业(600351.SH):ZY-A001获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658132","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511658132?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:33","pubTimestamp":1739518394,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚宝药业(600351.SH)发布公告,近日,公司收到了国家药品监督管理局核准签发的ZY-A001的《药物临床试验批准通知书》(通知书编号:2025LP00369),在进一步完善临床试验方案的基础上,同意本品开展用于儿童急性上呼吸道感染的确证性临床试验。ZY-A001的适应症为清热解毒,镇静安神,主要用于儿童急性上呼吸道感染的治疗。截至公告披露日,公司ZY-A001项目已投入研发费用约340.52万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4090","BK1576","BK0201","ZY","600351","BK0096","BK1141","BK4539","BK0077","03347","BK0239","BK0028"],"gpt_icon":0},{"id":"2462451351","title":"合成生物巨头,为什么一个个倒下了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2462451351","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2462451351?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:26","pubTimestamp":1724844360,"startTime":"0","endTime":"0","summary":"关于合成生物,有个重要却反直觉的趋势。另一方面,被视为合成生物灯塔的三只美股,近两年却迅速而惨烈的跌倒。首先是Amyris在去年宣布破产,今年更是接连出售数个化妆品和个护品牌。例如专注于医药产品的美国合成生物公司已经产生了强大的影响,微生物生产的蛋白质治疗药物和“生物制剂”已经占美国新批准药物的四分之一。初创公司 Pivot Bio 设计了两种土壤微生物菌株,并宣布已拿下了约 3%的美国市场。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-08-28/doc-incmfcme1693147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","BK4090","01477","ZY","BK1574","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymergen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":-0.0431},{"period":"3month","weight":-0.0453},{"period":"6month","weight":0.0071},{"period":"1year","weight":0.1014},{"period":"ytd","weight":-0.0205}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zymergen Inc.于2013年在特拉华州注册成立。他们与Nature合作,设计,开发和商业化基于生物的突破性产品,这些产品将为广泛行业的客户提供非凡的价值。他们的首批创新产品包括专为电子公司设计的,可用于新型智能设备(包括可卷起的平板电脑)和天然紫外线防护产品的薄膜。","exchange":"NASDAQ","name":"Zymergen, Inc.","nameEN":"Zymergen, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zymergen, Inc.(ZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zymergen, Inc.(ZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zymergen, Inc.,ZY,Zymergen, Inc.股票,Zymergen, Inc.股票老虎,Zymergen, Inc.股票老虎国际,Zymergen, Inc.行情,Zymergen, Inc.股票行情,Zymergen, Inc.股价,Zymergen, Inc.股市,Zymergen, Inc.股票价格,Zymergen, Inc.股票交易,Zymergen, Inc.股票购买,Zymergen, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zymergen, Inc.(ZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zymergen, Inc.(ZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}